What happens when you stop taking Mounjaro

Why your hunger comes back when tirzepatide clears your body

Mounjaro works by activating two receptors (GLP-1 and GIP) that are involved in signalling fullness, slowing gastric emptying, and regulating appetite. While tirzepatide is in your system, those signals are amplified. Stop the injections, and the medicine's half-life means its concentration falls over roughly one to two weeks, after which your body returns to its own baseline.

That baseline is where many people with obesity started: a state where hunger hormones like ghrelin are biologically elevated relative to people with lower body weights. This is not a character failing. It is the physiology that made losing weight difficult in the first place, and it is the same physiology that weight management medicines are designed to address. The NHS tirzepatide guidance describes this mechanism clearly, and it explains why stopping tends to mean appetite returns fairly quickly.

For some people, particularly those who have significantly changed their eating patterns and activity levels during treatment, the return of hunger is manageable. For others it feels abrupt, and reading about what to expect when tirzepatide leaves your system can help you prepare for that transition. Your prescriber is the right person to walk through what to expect given your specific dose history and how long you have been on treatment.

If you want to understand more about how the medicine acts during treatment, the effects of tirzepatide while you are taking it are worth reading before making a decision about stopping.

How much weight do people regain after stopping Mounjaro?

The honest answer is: it varies, and the trial data is sobering. Evidence from the broader tirzepatide and GLP-1 clinical programme consistently shows that a significant proportion of lost weight returns after treatment ends in participants who do not continue intensive lifestyle support. This mirrors findings from semaglutide trials, where participants who stopped treatment regained roughly two-thirds of their lost weight over a year without continued medicine.

This does not mean stopping is wrong for everyone. Some people reach a stable, healthier weight and maintain it with diet and exercise changes they have embedded during treatment. Others find that after a planned break they restart, which is a legitimate clinical option, provided a prescriber reviews suitability again before each course.

The key variable is what you carry forward from treatment. Protein intake, consistent activity, and a sustainable calorie pattern matter more after stopping than almost anything else. A Mounjaro injection course is most effective when it runs alongside genuine behavioural change, not instead of it.

For a broader look at your treatment options and what the evidence says about each, the weight-loss treatment overview sets out the landscape clearly.

Factors that shape the decision to stop, pause or continue

Stopping is not always a crisis, and continuing is not always the answer. Several things are worth thinking through with your prescriber before making a call.

First, why are you stopping? If it is cost, it is worth knowing that a full picture of what Mounjaro involves (including what a private prescription actually covers) sometimes changes the calculation. If it is side effects that have not settled, that is a clinical conversation about dose or timing, not necessarily a reason to stop altogether.

Second, how long have you been on treatment? People who have been on Mounjaro for several months and have lost meaningful weight have more to consider than someone a few weeks in.

Third, your reason for being prescribed it matters. If Mounjaro was prescribed partly for type 2 diabetes management, stopping has implications beyond weight that must involve your prescribing clinician and, where relevant, your GP.

Fourth, is a pause rather than a permanent stop the right framing? Some people plan a break and restart. This is clinically acceptable, though suitability must be assessed again before resuming, and a prescriber should be part of that review. The specifics of stopping Mounjaro for weight loss covers this in more detail.

One practical note: if you are currently partway through a course, your pen arrives with a DPD tracking notification and is delivered in plain packaging, so there is no urgency around the delivery itself. The clinical decision, though, benefits from not being rushed.

What to do next, whether you stop or carry on

If you are stopping, tell your prescriber before your next order rather than simply not reordering. They can note it, flag anything clinically relevant, and advise on monitoring, particularly for blood pressure or glucose if those were among your reasons for starting.

If you want to continue but have questions about your dose, your progress, or what the next few months might look like, that is exactly what aftercare is for. The frequently asked questions cover some of the most common concerns patients raise, and our clinical team is reachable seven days a week.

If you have not yet started treatment and are weighing up whether Mounjaro is right for you at all, the place to begin is a free consultation rather than a decision made in isolation. A GPhC-registered prescriber reviews each consultation personally (a real clinician reads your answers, not software) and can advise on whether treatment is appropriate, which dose to start at, and what realistic expectations look like for your situation. You can start your free consultation at any point.

For context on what other patients have found during treatment, Mounjaro injection reviews offer a grounded picture, though individual results vary, and no outcome is guaranteed. The clinical team at nume is happy to discuss any aspect of treatment, stopping, or restarting at any stage.